Anti-Canine CD20/CD20 Reference Antibody|抗犬CD20/CD20参照抗体(靶标：犬CD20双价抗体(研究用))
- 货号：RB9TCY257026
- 价格：面议
- 点击：450
产品介绍
产品参数
| 形态 | Liquid |
|---|---|
| 宿主种属 | Canis |
| 克隆性 | Monoclonal |
| 抗体亚型 | IgG2, lambda |
| 纯度 | >95% as determined by SDS-PAGE. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 内毒素水平 | < 10 EU/mg |
| 应用 | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| 种属反应性 | canine |
| 储存缓冲液 | 0.01 M PBS pH 7.4 |
| 稳定性和储存 | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -117°C long term. |
| 产品使用说明 | ELISA: 1:2000-1:20000 |
| 登录号 | Q3C2E2 |
| 背景信息 | B-lymphocyte antigen CD20 (MS4A1) is a ~33 kDa protein. B-lymphocyte-specific membrane protein that plays a role in the regulation of cellular calcium influx necessary for the development, differentiation, and activation of B-lymphocytes. Functions as a store-operated calcium (SOC) channel component promoting calcium influx after activation by the B-cell receptor/BCR. CD20 is the therapeutic target of rituximab (MabThera) and obinutuzumab (Gazyva). |
| 备注 | For research use only. |
相关产品: